Randomized controlled trials of remdesivir in hospitalized coronavirus disease 2019 patients: A meta-analysis

BACKGROUND: The first cases of the coronavirus disease 2019 (COVID-19) were reported in Wuhan, China. No antiviral treatment options are currently available with proven clinical efficacy. However, preliminary findings from phase III trials suggest that remdesivir is an effective and safe treatment o...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarfraz, Azza, Sarfraz, Zouina, Sanchez-Gonzalez, Marcos, Michel, Jack, Michel, George, Frontela, Odalys, Posada, Jorge, Cardona, Jose, Angueira, Eugenio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091999/
https://www.ncbi.nlm.nih.gov/pubmed/33969238
http://dx.doi.org/10.4103/2452-2473.309139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091999/
https://www.ncbi.nlm.nih.gov/pubmed/33969238
http://dx.doi.org/10.4103/2452-2473.309139

Ejemplares similares